782 related articles for article (PubMed ID: 30959275)
1. Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study.
Del Bianco C; Placidi F; Liguori C; Mari L; Ulivi M; Ornello R; Pisani A; Mercuri NB; Izzi F
Epilepsy Behav; 2019 May; 94():178-182. PubMed ID: 30959275
[TBL] [Abstract][Full Text] [Related]
2. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of adjuvant lacosamide: The role of clinical characteristics and mechanisms of action of concomitant AEDs.
Neal A; D'Souza W; Hepworth G; Lawn N; Cook M; Nikpour A
Epilepsy Behav; 2018 Mar; 80():25-32. PubMed ID: 29396359
[TBL] [Abstract][Full Text] [Related]
4. Equipotency of lacosamide to levetiracetam in new onset focal epilepsy: A randomized controlled trial.
Jaiswal BK; Bhoi SK; Jha M; Samal P; Porey C
J Neurosci Rural Pract; 2023; 14(4):622-628. PubMed ID: 38059231
[TBL] [Abstract][Full Text] [Related]
5. Lacosamide as first add-on or conversion monotherapy: A retrospective real-life study.
Casciato S; Quarato PP; Gialluisi A; D'Aniello A; Mascia A; Grammaldo LG; Di Gennaro G
Epilepsy Behav; 2021 Sep; 122():108128. PubMed ID: 34229159
[TBL] [Abstract][Full Text] [Related]
6. Prospective audits with newer antiepileptic drugs in focal epilepsy: insights into population responses?
Brodie MJ; Kelly K; Stephen LJ
Epilepsy Behav; 2014 Feb; 31():73-6. PubMed ID: 24361766
[TBL] [Abstract][Full Text] [Related]
7. Retrospective comparison of efficacy of levetiracetam and lacosamide add-on treatments in patients with partial onset seizure.
Acar T; Aras YG
Ideggyogy Sz; 2018 May; 71(5-06):197-204. PubMed ID: 29889462
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of immediate switch from sodium channel blockers to Lacosamide.
Talha Özgün O; Kandemir Yılmaz M; Mert Atmaca M; Keskin Güler S; Buluş E; Duman A; Çelebi Ö; Gürses C
Epilepsy Behav; 2023 Aug; 145():109355. PubMed ID: 37473655
[TBL] [Abstract][Full Text] [Related]
9. Lacosamide and sodium channel-blocking antiepileptic drug cross-titration against levetiracetam background therapy.
Baulac M; Byrnes W; Williams P; Borghs S; Webster E; De Backer M; Dedeken P
Acta Neurol Scand; 2017 Apr; 135(4):434-441. PubMed ID: 27714769
[TBL] [Abstract][Full Text] [Related]
10. Perampanel and lacosamide monotherapy in pediatric patients with newly diagnosed focal epilepsy: A prospective study evaluating efficacy, tolerability, and behavior.
Zhou R; Qu R; Liu M; Huang DP; Zhou JY; Chen Y; Chen XQ
Epilepsy Behav; 2023 Sep; 146():109353. PubMed ID: 37481960
[TBL] [Abstract][Full Text] [Related]
11. Antiepileptic monotherapy in newly diagnosed focal epilepsy. A network meta-analysis.
Lattanzi S; Zaccara G; Giovannelli F; Grillo E; Nardone R; Silvestrini M; Trinka E; Brigo F
Acta Neurol Scand; 2019 Jan; 139(1):33-41. PubMed ID: 30194755
[TBL] [Abstract][Full Text] [Related]
12. Adjunctive lacosamide in clinical practice: sodium blockade with a difference?
Stephen LJ; Kelly K; Parker P; Brodie MJ
Epilepsy Behav; 2011 Nov; 22(3):499-504. PubMed ID: 21890421
[TBL] [Abstract][Full Text] [Related]
13. Long-term efficacy and safety of lacosamide monotherapy in the treatment of partial-onset seizures: A multicenter evaluation.
Giráldez BG; Toledano R; García-Morales I; Gil-Nagel A; López-González FJ; Tortosa D; Ojeda J; Serratosa JM
Seizure; 2015 Jul; 29():119-22. PubMed ID: 26076854
[TBL] [Abstract][Full Text] [Related]
14. Lacosamide in monotherapy in BTRE (brain tumor-related epilepsy): results from an Italian multicenter retrospective study.
Mo F; Meletti S; Belcastro V; Quadri S; Napolitano M; Bello L; Dainese F; Scarpelli M; Florindo I; Mascia A; Pauletto G; Bruno F; Pellerino A; Giovannini G; Polosa M; Sessa M; Conti Nibali M; Di Gennaro G; Gigli GL; Pisanello A; Cavallieri F; Rudà R
J Neurooncol; 2022 May; 157(3):551-559. PubMed ID: 35397759
[TBL] [Abstract][Full Text] [Related]
15. LACONORTE study: Efficacy and security of lacosamide as first add-on therapy for focal-onset epilepsy in real-life setting.
Muñoz-Lopetegi A; López-González FJ; Rodríguez-Osorio X; Pato Pato A; Bellas Lamas P; Abella-Corral J; Castro Vilanova MD; Garea MJ; Gil López JA; Ruiz-Martínez J; Poza JJ
Epilepsy Res; 2018 Sep; 145():51-54. PubMed ID: 29890341
[TBL] [Abstract][Full Text] [Related]
16. The challenges of assessing effectiveness of lacosamide using electronic medical record databases.
Kalilani L; Halpern R; Seare J; Dedeken P
Epilepsy Behav; 2018 Aug; 85():195-199. PubMed ID: 30032807
[TBL] [Abstract][Full Text] [Related]
17. A prospective, multicenter, noninterventional study in Taiwan to evaluate the safety and tolerability of lacosamide as adjunctive therapy for epilepsy in clinical practice.
Wu T; Chuang YC; Huang HC; Lim SN; Hsieh PF; Lee WT; Cheng MY; Tsai MH; Jou SB; Chang CW; Hsieh HY; Du X; Hellot S; McClung C; Hung C
Epilepsy Behav; 2020 Dec; 113():107464. PubMed ID: 33152580
[TBL] [Abstract][Full Text] [Related]
18. Effect of Levetiracetam Monotherapy in Nonlesional Focal Childhood Epilepsy.
Kanemura H; Sano F; Ohyama T; Sugita K; Aihara M
Neuropediatrics; 2018 Apr; 49(2):135-141. PubMed ID: 29253909
[TBL] [Abstract][Full Text] [Related]
19. Polygonogram and isobolographic analysis of interactions between various novel antiepileptic drugs in the 6-Hz corneal stimulation-induced seizure model in mice.
Luszczki JJ; Panasiuk A; Zagaja M; Karwan S; Bojar H; Plewa Z; Florek-Łuszczki M
PLoS One; 2020; 15(6):e0234070. PubMed ID: 32479532
[TBL] [Abstract][Full Text] [Related]
20. [Russian experience of lacosamide (vimpat) usage in treatment of uncontrolled focal epilepsy].
Lebedeva AV; Burd SG; Belyaev OV; Vlasov PN; Dorofeeva MY; Ismailov AM; Kissin MY; Kovaleva IY; Koroleva NY; Lipatova LV; Mukhin KY; Solomatin YV; Chervyakov AV; Shikhkerimov RG; Pylaeva OA; Freidkova NV
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(9. Vyp. 2):74-81. PubMed ID: 28005051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]